The Global Cancer Monoclonal Antibodies Market size was valued at $55.6 billion in 2021, and is projected to reach $106.8 billion by 2031, growing at a CAGR of 7% from 2022 to 2031. Cancer monoclonal antibodies (mAbs) are a type of immunotherapy that target cancer cells by binding to specific proteins on their surface. They are used …